Specializing in benign hematologic disorders, Dominika serves as a liaison between Versiti’s Hematology Genetics laboratory and ordering providers working to optimize genetic test utilization. She also aids in report writing, test development, research initiatives and continuous improvement projects.

Prior to joining Versiti, Dominika worked for Novant Health Cancer Institute as an Oncology Genetic Counselor in Winston Salem, NC. In this role, she provided genetic counseling to patients with a personal or family history of cancer and worked closely with advanced practice providers to help direct care for individuals with an increased risk of developing cancer.

Dominika has a strong interest in laboratory stewardship, with research focused on understanding current genetic testing ordering trends, and inherited coagulation deficiencies. Additionally, she enjoys supervising genetic counseling students from the Medical College of Wisconsin.

1. Bajguz, D., Danylchuk, N. R., Czarniecki, M., Selig, J. P., Sutphen, R., & Kaylor, J. (2022). Utilization of genetic testing: Analysis of 4,499 prior authorization requests for molecular genetic tests at four US regional health plans. Journal of Genetic Counseling, 31, 771– 780. https://doi.org/10.1002/jgc4.1543

Abstracts/Posters

1. Bajguz DA, Trapp-Stamborski V, Palmer EL, Smith CC, Czajkowski CD, Meyers SJ, Miller AP, Dugan SN, Friedman KD, Perez Botero J. When is factor VIII deficiency not hemophilia A? Variant F8 c.1094 A>G, p.Tyr365Cys illustrates the utility of genotyping and the value of disease specific expertise in variant classification. International Society on Thrombosis and Haemostasis (ISTH) 2023 Annual Congress, Montreal, Canada, June 2023.
2. Smith CC, Bajguz DA, Palmer EL, Perez Botero J, Dugan SN, Riley JD. Overutilization of rare disease testing: An Exploration of ADAMTS13 Genetic Analysis. PLUGS Summit 2023, Seattle, WA, June 2023.